Shkreli, Martin

Shkreli, Martin
	Affiliated Entities       Desert Gateway, Inc. Kalobios Pharmaceuticals, Inc.

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	1/27/2020	New York Southern District Court	1:20-cv-00706-DLC	Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC...	Defendant
	1/27/2020	New York Southern District Court	1:20-cv-00706-DLC	Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC...	Defendant
	9/14/2016	New York Southern District Court	1:16-cv-07175	Koestler v. Shkreli	Respondent
	2/9/2016	New York Southern District Court	1:16-cv-00956	Koza v. Diggs et al	Defendant
	12/31/2015	California Northern District Court	3:15-cv-06331	Isensee v. KaloBios Pharmaceuticals, Inc. et al	Defendant
	12/23/2015	California Northern District Court	3:15-cv-05992	Sciabacucchi v. KaloBios Pharmaceuticals, Inc. et al	Defendant
	12/18/2015	California Northern District Court	3:15-cv-05841	In Re: KALOBIOS PHARMACEUTICALS, INC. SECURITIES LITIGATION	Defendant
	12/17/2015	New York Eastern District Court	1:15-cv-07175	Securities And Exchange Commission v. Shkreli et al	Defendant
	12/14/2015	New York Eastern District Court	1:15-cr-00637-KAM	USA v. Shkreli et al	Defendant (1)
	12/14/2015	New York Eastern District Court	1:15-cr-00637-KAM-1	USA v. Shkreli et al	Defendant (1)
	8/17/2015	New York Southern District Court	1:15-cv-06451	Retrophin, Inc. v. Shkreli	Defendant
	12/16/2014	New York Southern District Court	1:14-cv-09915	Sandler v. Retrophin, Inc. et al	Defendant
	12/3/2014	New York Southern District Court	1:14-cv-09538	Gibbons v. Shkreli et al	Defendant
	10/20/2014	New York Southern District Court	1:14-cv-08376-PKC	Kazanchyan v. Retrophin, Inc. et al	Defendant
	9/19/2014	New York Southern District Court	1:14-cv-07640	Donoghue et al v. Retrophin, Inc. et al	Defendant
	9/25/2013	New York Southern District Court	1:13-cv-06780	Trustees of the New York City District Council of Carpenters...	Defendant

16 Rows Total

Outside Counsel (12)

	Last Name	First Name	Middle Name	Firm	Location
	Buckley	Peter	C.	Fox Rothschild LLP	PHILADELPHIA, PA
	Chrestionson	Keith	I.	Fox Rothschild LLP	San Francisco, CA
	Finkelstein	Bret	A.	Arnold & Porter, LLP	New York, NY
	Huang	Wendy	Wei-Wenne	King & Spalding LLP	Ny 10036,
	Jacobson	Jocelyn	L.	Reitler Kailas & Rosenblatt, LLC	New York, NY
	Katz	Dana	Sichel	Fox Rothschild LLP	New York, NY
	Marooney	Richard	T.	King & Spalding LLP	Ny 10036,
	Nuchow	Scott	Alan	O.t.d.a.	Brooklyn, NY
	Preheim	Elissa	J.	Arnold & Porter, LLP	Washington, DC
	Stassen	William		Fox Rothschild LLP	Philadelphia, PA
	Vernick	Scott	L.	Fox Rothschild LLP	PHILADELPHIA, PA
	Weiss	Baruch		Arnold & Porter, LLP	Washington, DC

12 Rows Total

Filter By Form All Records 144 3 4 4/A SC 13D SC 13D/A From To

	Date	Entity	Form Number	Description
	8/29/2016		SC 13D/A
	8/29/2016	Kalobios Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	11/25/2015		SC 13D
	11/24/2015	Kalobios Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	11/23/2015	Kalobios Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	11/19/2015	Kalobios Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	11/18/2015	Kalobios Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	11/18/2015	Kalobios Pharmaceuticals, Inc.	3	Initial statement of beneficial ownership of securities
	11/24/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	11/24/2014		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	10/9/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	10/2/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	9/23/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	9/18/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	9/16/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	6/3/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	4/7/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	4/4/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	4/3/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/27/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/21/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/20/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/17/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/12/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/11/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/10/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/6/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/4/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/3/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	2/25/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	2/19/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	2/7/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	1/15/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	1/14/2014	Desert Gateway, Inc.	4/A
	1/2/2014	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	12/10/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	12/2/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	9/16/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	8/23/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	5/2/2013		SC 13D/A
	3/12/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	3/6/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	2/21/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	2/19/2013		SC 13D/A
	2/19/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2013	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	12/28/2012	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	12/26/2012	Desert Gateway, Inc.	4	Statement of changes in beneficial ownership of securities
	12/20/2012		SC 13D
	2/22/2012		SC 13D/A

52 Rows Total	Page 1 of 2 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	10/1/2018	Retrophin, Inc.	Assignee	Application Publication	15863683 20180291045	Pantothenate Derivatives For The Treatment Of Neurological Disorders Pantothenate Derivatives For The Treatment Of Neurological Disorders
	10/1/2018	Retrophin, Inc.	Assignee	Application Publication Patent	15863683 20180291045 10407447	Pantothenate Derivatives For The Treatment Of Neurological Disorders Pantothenate Derivatives For The Treatment Of Neurological Disorders Pantothenate Derivatives For The Treatment Of Neurological Disorders
	7/8/2016	Retrophin, Inc.	Assignee	Application Application Publication Publication Patent	14871450 14157173 20140135294 20160015727 9181286	Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders
	7/8/2016	Retrophin, Inc.	Assignee	Application Application Publication Publication Patent Patent	14871450 14157173 20160015727 20140135294 9629862 9181286	Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders
	6/8/2016	Retrophin, Inc.	Assignee	Application Publication	15031691 20160264607	Panothenate Derivatives For The Treatment Of Neurological Disorders Panothenate Derivatives For The Treatment Of Neurological Disorders
	6/8/2016	Retrophin, Inc.	Assignee	Application Publication Patent	15031691 20160264607 9896464	Panothenate Derivatives For The Treatment Of Neurological Disorders Panothenate Derivatives For The Treatment Of Neurological Disorders Pantothenate Derivatives For The Treatment Of Neurological Disorders
	10/25/2013	Retrophin, Inc.	Assignee	Application Publication Patent	13871691 20130289001 8673883	Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders Pantothenate Derivatives For The Treatment Of Neurologic Disorders

7 Rows Total

Shkreli, Martin has not been involved in any trademark assignment transactions in the PlainSite database.

Affiliated Entities

• Desert Gateway, Inc.
• Kalobios Pharmaceuticals, Inc.

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.